-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, the guidelines for the diagnosis and treatment of rheumatoid arthritis (RA) by clinical experts have been continuously updated.
01RA is a chronic, systemic, autoimmune disease;
02 A positive rheumatoid factor (RF) alone cannot diagnose RA;
03RA has a certain genetic predisposition;
04 Anti-cyclic citrullinated polypeptide (CCP) antibody testing predicts the severity of joint destruction in patients with RA;
05Acupuncture can assist in the treatment of RA;
06 RA patients with anxiety symptoms can seek psychological intervention and drug treatment;
07 RA patients with sleep disorders can try psychological intervention or drug treatment, and appropriate exercise;
08RA patients should participate in exercise and choose appropriate exercise methods according to their condition;
09RA patients should quit smoking;
10 For patients with RA who have discontinued glucocorticoids and have been in remission for more than half a year, dose reduction of biological agents can be considered;
11 Methotrexate is contraindicated during pregnancy and lactation, and pregnancy can be prepared if it is stopped for more than 3 months;
12 Leflunomide is contraindicated during pregnancy and lactation, and pregnancy can be prepared when the concentration of the drug is not detected in the blood;
13 RA patients should be supplemented with calcium, vitamin D and bisphosphonates to prevent and/or treat osteoporosis;
14 Color ultrasonography for synovitis in stable RA patients predicts disease recurrence;
15RA patients should pay attention to the prevention, monitoring and treatment of liver injury;
16RA patients benefit greatly from participating in the fellowship